Tango Therapeutics

126 people · 0 jobs
‌

Tango Therapeutics is a biotechnology company discovering and developing novel medicines targeting cancer vulnerabilities to deliver transformational new therapies for patients.

Industries

Employees

11-50

Links


Org chart

Barbara Weber
President & CEO
Collapse
Daniella Beckman
Chief Financial Officer
Jannik N. Andersen
Chief Scientific Officer
Doug Barry
Chief Legal Officer
Drew Sansone
Chief Regulatory Officer
Adam Crystal
President, Research & Development
Elizabeth Hickin
Vp, Investor Relations And Corporate Communications
Yong Liu
Executive Director
Julie Carretero
Chief Human Resources Officer

Board & advisors

Alan Ashworth
Scientific Advisor
Ulrich Elling
Scientific Advisor
William G. Kaelin
Scientific Advisor
Antoni Ribas
Scientific Advisor
John G. Doench
Scientific Advisor
Malte Peters
Director
John Ketchum
Director